Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) frequently detects metastatic disease missed by conventional imaging, investigators report.

Metastatic prostate cancer can progress in different ways. In some men the disease advances rapidly, while other men have slower-growing cancer and a better prognosis. Researchers are developing ...

Scientists at Heriot Watt University developed a cost-effective technique for faster, more accurate prostate cancer detection ...

A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk ...

Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought. A new study led by researchers at the UCLA Health ...

The ARANOTE, PEACE-3, and SPLASH trials showcased new treatment options in advanced prostate cancer. ARANOTE confirmed darolutamide + ADT improves rPFS in mHSPC, while PEACE-3 demonstrated that ...

The study, published in JAMA Network Open, found that nearly half of high-risk prostate cancer patients previously classified as nonmetastatic by conventional imaging actually have metastatic ...

Prostate cancer is one of the most common types of cancer among men in the UK, and one of the most deadly. Here are the ...

Health experts have warned that back pain “that doesn’t go away with rest” could signal cancer. According to Cancer Research ...